EXOSURF NEONATAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Exosurf Neonatal, and when can generic versions of Exosurf Neonatal launch?
Exosurf Neonatal is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in EXOSURF NEONATAL is cetyl alcohol; colfosceril palmitate; tyloxapol. There are ninety-one drug master file entries for this compound. Additional details are available on the cetyl alcohol; colfosceril palmitate; tyloxapol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EXOSURF NEONATAL?
- What are the global sales for EXOSURF NEONATAL?
- What is Average Wholesale Price for EXOSURF NEONATAL?
Summary for EXOSURF NEONATAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EXOSURF NEONATAL at DailyMed |
![EXOSURF NEONATAL drug patent expirations Drug patent expirations by year for EXOSURF NEONATAL](/p/graph/s/t/EXOSURF_NEONATAL-patent-expirations.png)
Recent Clinical Trials for EXOSURF NEONATAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NICHD Neonatal Research Network | Phase 2/Phase 3 |
US Patents and Regulatory Information for EXOSURF NEONATAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EXOSURF NEONATAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EXOSURF NEONATAL
See the table below for patents covering EXOSURF NEONATAL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 19375071 | ⤷ Sign Up | |
Bulgaria | 60737 | ⤷ Sign Up | |
Japan | S5799524 | MAMMAL LUNG SURFACE ACTIVE DRUG COMPOSITION | ⤷ Sign Up |
Canada | 1184503 | SURFACTANT SYNTHETIQUE (LUNG SURFACTANT COMPOSITIONS) | ⤷ Sign Up |
European Patent Office | 0050793 | LUNG SURFACTANT COMPOSITIONS | ⤷ Sign Up |
Mexico | 9203533 | COMPOSICIONES AGENTES TENSIOACTIVOS PULMONARES. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for EXOSURF NEONATAL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0050793 | SPC/GB93/042 | United Kingdom | ⤷ Sign Up | SPC/GB93/042, EXPIRES: 20051213 |
0257344 | C990001 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DIPYRIDAMOL, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AAN- VAARDBAAR ZOUT, EN ACETYLSALICYLZUUR, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AANVAARDBAAR ZOUT,IN EEN GEWICHTSVERHOUDING TUSSEN DIPYRIDAMOL-BESTANDDEEL EN ACETYLSALICYLZUUR-BESTANDDE; NAT. REGISTRATION NO/DATE: RVG 21171 19980713; FIRST REGISTRATION: FR 343 234.9, 560 483.7 19970709 |
0257344 | 20/1999 | Austria | ⤷ Sign Up | PRODUCT NAME: DIPYRIDAMOL IN KOMBINATION MIT ACETYLSALICYLSAEURE; NAT. REGISTRATION NO/DATE: 1-22779 19981112; FIRST REGISTRATION: FR NL 22160 19970709 |
0984957 | 1290006-4 | Sweden | ⤷ Sign Up | PRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812 |
0984957 | C300517 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ACETYLSALICYLZUUR EN ESOMEPRAZOLMAGNESIUMTRIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 107516 20110912; FIRST REGISTRATION: 540235954023675402375 2011120812 |
0257344 | SPC/GB98/043 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DIPYRIDAMOLE, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY ACCEPTABLE SALT, AND O-ACETYLSALICYLIC ACID, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY SALT, I.E. ASASANTIN RETARD; REGISTERED: FR NL 22160 19970709; UK 00015/0224 19980512 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |